Skip to main content
Clinical Trials/NCT05548764
NCT05548764
Completed
Not Applicable

Prevention Bundles for Surgical Site Infections (PREBUSSI): a Multi-center Observational Study.

Maximos Frountzas1 site in 1 country200 target enrollmentOctober 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Surgical Site Infection
Sponsor
Maximos Frountzas
Enrollment
200
Locations
1
Primary Endpoint
Incidence of SSIs
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Surgical site infections (SSIs) are the most complication after a surgical operation and their incidence reaches 20% worldwide. SSIs have been associated to significant morbidity and mortality, high ICU admission rates, increased length of hospital stay, high readmission rates and raised cost. However, there is no registry for SSIs in Greece so far. In addition, it has been considered that almost half of SSIs could be prevented. Therefore, several prevention strategies have been suggested by international health organizations, such as WHO and NICE, that seem to be effective. The aim of the present study is to investigate the effect of 10 prevention bundles on the rate of SSIs, as well their consequences on several financial parameters of the Greek healthcare system.

Detailed Description

* 1st phase (2 months) → SSIs rate among abdominal surgical operations and reporting of patients' demographics (gender, age, comorbidities), type of surgery (upper GI, HPB, colorectal), surgical approach (open, laparoscopic), urgency classification, operation time, cost, pathogen cultures and antibiotic sensitivity test. * 2ο phase (10 months) → implementation of 10 prevention bundles: 1. Antibiotic delivery 1-1.5 hours before surgical incision and repeat every 4 hours intraoperatively. 2. Hair removal with electric hair clippers using single-use bladdes. 3. Surgical scrub with Povidone Iodine solution 4% (Betadine Surgical Scrub) 4. Skin preparation with chlorexidine alcohol-based antiseptic solution 2%. 5. Intraoperative and postoperative (4-6 hours) normothermia (\>36οC) using warmed forced-air blankets. 6. Perioperative normoglycemia (Glu\<200mg/dl) in diabetic patients. 7. Single-use drapes and gowns. 8. Surgical team glove changing by before skin incision closing. 9. Single-layer surgical incision closure with triclosan plus antimicrobial-coated sutures. 10. Wound irrigation (skin and subcutaneous fat) with Povidone Iodine solution (Betadine) after abdominal wall closure. * Implementation check of 10 prevention bundles preoperatively, intraoperatively and postoperatively. * Clinical assessment on POD 1, 3, 7 and 1 month postoperatively for SSI presence (according to WHO 2018 definition). * Reporting of patients' demographics (gender, age, comorbidities), type of surgery (upper GI, HPB, colorectal), surgical approach (open, laparoscopic), urgency classification, operation time, length of stay, cost, pathogen cultures and antibiotic sensitivity test.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
December 20, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Maximos Frountzas
Responsible Party
Sponsor Investigator
Principal Investigator

Maximos Frountzas

Maximos Frountzas MD MPA PhD

National and Kapodistrian University of Athens

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years old
  • Signed consent from patient or authorized representative
  • Abdominal surgery
  • Open or laparoscopic operations

Exclusion Criteria

  • Age \< 18 years old
  • No signed consent from patient or authorized representative
  • Neck, thoracic, anal, lumbar operations
  • No closure of abdominal wall or open abdomen

Outcomes

Primary Outcomes

Incidence of SSIs

Time Frame: 30 days

Rate of SSIs after implementation of prevention bundles

Secondary Outcomes

  • Pathogen cultures(30 days)
  • Antibiotic sensitivity test(30 days)
  • Cost(30 days)
  • Length of hospital stay(30 days)
  • Implementation of guidelines(30 days)

Study Sites (1)

Loading locations...

Similar Trials